Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting
<p>Abstract</p> <p>Background</p> <p>To assess differences in outpatient costs among pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting.</p> <p>Methods</p> <p>A retrospective case...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-02-01
|
Series: | BMC Health Services Research |
Online Access: | http://www.biomedcentral.com/1472-6963/12/46 |
_version_ | 1818443837572382720 |
---|---|
author | Bosmans Judith E Adriaanse Marcel C |
author_facet | Bosmans Judith E Adriaanse Marcel C |
author_sort | Bosmans Judith E |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>To assess differences in outpatient costs among pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting.</p> <p>Methods</p> <p>A retrospective case control study over 3 years (2002-2004). Data on 7128 depressed patients and 23772 non-depressed matched controls were available from the electronic medical record system of 20 general practices organized in one large primary care organization in the Netherlands. A total of 393 depressed patients with diabetes and 494 non-depressed patients with diabetes were identified in these records. The data that were extracted from the medical record system concerned only outpatient costs, which included GP care, referrals, and medication.</p> <p>Results</p> <p>Mean total outpatient costs per year in depressed diabetes patients were €1039 (SD 743) in the period 2002-2004, which was more than two times as high as in non-depressed diabetes patients (€492, SD 434). After correction for age, sex, type of insurance, diabetes treatment, and comorbidity, the difference in total annual costs between depressed and non-depressed diabetes patients changed from €408 (uncorrected) to €463 (corrected) in multilevel analyses. Correction for comorbidity had the largest impact on the difference in costs between both groups.</p> <p>Conclusions</p> <p>Outpatient costs in depressed patients with diabetes are substantially higher than in non-depressed patients with diabetes even after adjusting for confounders. Future research should investigate whether effective treatment of depression among diabetes patients can reduce health care costs in the long term.</p> |
first_indexed | 2024-12-14T19:06:23Z |
format | Article |
id | doaj.art-404b48d1a75740d697d0db179da36179 |
institution | Directory Open Access Journal |
issn | 1472-6963 |
language | English |
last_indexed | 2024-12-14T19:06:23Z |
publishDate | 2012-02-01 |
publisher | BMC |
record_format | Article |
series | BMC Health Services Research |
spelling | doaj.art-404b48d1a75740d697d0db179da361792022-12-21T22:50:50ZengBMCBMC Health Services Research1472-69632012-02-011214610.1186/1472-6963-12-46Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care settingBosmans Judith EAdriaanse Marcel C<p>Abstract</p> <p>Background</p> <p>To assess differences in outpatient costs among pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting.</p> <p>Methods</p> <p>A retrospective case control study over 3 years (2002-2004). Data on 7128 depressed patients and 23772 non-depressed matched controls were available from the electronic medical record system of 20 general practices organized in one large primary care organization in the Netherlands. A total of 393 depressed patients with diabetes and 494 non-depressed patients with diabetes were identified in these records. The data that were extracted from the medical record system concerned only outpatient costs, which included GP care, referrals, and medication.</p> <p>Results</p> <p>Mean total outpatient costs per year in depressed diabetes patients were €1039 (SD 743) in the period 2002-2004, which was more than two times as high as in non-depressed diabetes patients (€492, SD 434). After correction for age, sex, type of insurance, diabetes treatment, and comorbidity, the difference in total annual costs between depressed and non-depressed diabetes patients changed from €408 (uncorrected) to €463 (corrected) in multilevel analyses. Correction for comorbidity had the largest impact on the difference in costs between both groups.</p> <p>Conclusions</p> <p>Outpatient costs in depressed patients with diabetes are substantially higher than in non-depressed patients with diabetes even after adjusting for confounders. Future research should investigate whether effective treatment of depression among diabetes patients can reduce health care costs in the long term.</p>http://www.biomedcentral.com/1472-6963/12/46 |
spellingShingle | Bosmans Judith E Adriaanse Marcel C Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting BMC Health Services Research |
title | Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting |
title_full | Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting |
title_fullStr | Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting |
title_full_unstemmed | Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting |
title_short | Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting |
title_sort | outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a dutch primary care setting |
url | http://www.biomedcentral.com/1472-6963/12/46 |
work_keys_str_mv | AT bosmansjudithe outpatientcostsinpharmaceuticallytreateddiabetespatientswithandwithoutadiagnosisofdepressioninadutchprimarycaresetting AT adriaansemarcelc outpatientcostsinpharmaceuticallytreateddiabetespatientswithandwithoutadiagnosisofdepressioninadutchprimarycaresetting |